MICHELLE GAVALA: Open Payments
NPI 1881058436 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 19 payments from 9 companies in 2025. Trend: 2023 $458 · 2024 $260 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 5 | $88 |
| Astellas Pharma US Inc | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $58 |
| Hologic Sales and Service, LLC | 1 | $42 |
| Exeltis, USA Inc. | 2 | $36 |
| Organon LLC | 2 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $31 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $15 |
Products named: Veozah, APTIMA, FEMLYV, SLYND, INTRAROSA, Mirena, Lynkuet, JADA SYSTEM.
Industry payments across NJ — which companies pay providers there.
